Glossary · Clinical

Facet joint injection

A facet joint injection delivers a diagnostic or therapeutic agent—typically corticosteroid with or without local anesthetic—directly into a paravertebral (zygapophysial) joint or onto the medial branch nerves that supply it, under fluoroscopic or CT guidance, to identify or treat axial spine pain.

Verified May 8, 2026 · 7 sources ↓

Drawn from CMSAAPCHiacodePgmbillingBcbsnm

Definition

Source · Editorial summary grounded in 7 cited references ↓

Facet joints (also called zygapophysial or Z-joints) are paired synovial joints at every spinal level connecting adjacent vertebrae posteriorly. Each joint is innervated by two medial branch nerves. When these joints degenerate or become inflamed, they can generate cervical, thoracic, or lumbar pain that is often poorly localized and does not follow a clear dermatomal pattern.

An injection into or around these joints serves two distinct purposes. Used diagnostically, a short-acting anesthetic is injected to determine whether the facet joint is the pain generator; a meaningful percentage reduction in pain (threshold defined by payer policy, commonly ≥50–80%) constitutes a positive response and can justify downstream radiofrequency ablation. Used therapeutically, a corticosteroid preparation is injected to reduce intra-articular inflammation and provide intermediate-term pain relief. All interventions—intra-articular or medial branch block—must be performed under fluoroscopic or CT guidance; procedures performed without imaging cannot be reported with the 6449x family of CPT codes.

Coding distinguishes by spinal region (cervical/thoracic vs. lumbar/sacral), level number (first level vs. second vs. third additional), and laterality (unilateral vs. bilateral). Ultrasound guidance invokes a separate, category-III code set (0213T–0218T) rather than the standard category-I codes. Radiofrequency neurotomy (chemodenervation or thermal ablation) of the medial branch nerves is coded separately and follows its own unit and laterality rules.

Why it matters

Incorrect laterality reporting—reporting two unilateral codes instead of one code with modifier -50 for bilateral injections, or stacking add-on codes when the same-side multi-level rules should apply—is one of the highest-frequency OIG and payer audit triggers for interventional pain and orthopedic practices. Medicare specifically prohibits separate billing for image guidance (it is bundled into 64490–64495), so unbundling fluoroscopy will generate an automatic denial. Billing anesthesia (MAC, moderate sedation, or general anesthesia) alongside facet injection codes is considered not reasonable and necessary by CMS, and the anesthesia line will deny outright. Because the KX modifier gates whether a diagnostic injection meets coverage criteria under Medicare LCDs, omitting it on the first two diagnostic injections—or overusing it beyond those initial sessions—can trigger focused medical review and potential recoupment.

Common mistakes

Where people most often go wrong with this concept.

Source · Editorial brief grounded in cited references ↓

Reporting two unilateral codes (e.g., 64493-LT and 64493-RT) instead of one code with modifier -50 for bilateral same-level injections—required by CMS and most commercial payers.
Using modifier -50 when injections are performed at multiple levels on the same side; additional ipsilateral levels require add-on codes (64491/64492 or 64494/64495), not modifier -50.
Billing image guidance (e.g., 77002 for fluoroscopy) separately from 64490–64495; guidance is bundled into the procedure codes and cannot be unbundled.
Reporting 64633–64636 (radiofrequency ablation) for non-thermal or pulsed radiofrequency denervation; those services must use 64999, which is non-covered under Medicare.
Appending the KX modifier to therapeutic (non-diagnostic) injections or to more than the two initial diagnostic sessions without documentation that a different level needed to be tested after a negative response.
Reporting one unit per nerve rather than one unit per joint for chemodenervation codes 64633–64636; the code is per joint regardless of how many nerves were treated.
Billing moderate sedation, MAC, or general anesthesia alongside facet injection codes; CMS deems these not reasonable and necessary, and the anesthesia claim line will deny.
Using the standard category-I codes (64490–64495) when ultrasound was the guidance modality; ultrasound-guided facet injections require category-III codes 0213T–0218T instead.
Injecting biologicals or non-approved substances into facet joints; under CMS policy, this causes the entire claim to deny, not just the individual line.

Related codes

Codes commonly involved when this concept appears in practice.

ICD-10

M54.2 M54.6 M54.9

Modifiers

50 Bilateral procedure LT Left side RT Right side KX Medical-policy requirements met 59 Distinct procedural service 76 Repeat procedure same physician 77 Repeat procedure another physician

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 7 cited references ↓

01When should I use modifier -50 versus add-on codes for facet injections?

Use modifier -50 when you inject both sides of the same vertebral level (e.g., bilateral L3-4). Use the add-on codes (64491/64492 for cervical/thoracic; 64494/64495 for lumbar/sacral) when you inject additional levels on the same side. Mixing these up is one of the most common audit triggers.

02Is fluoroscopy billed separately for facet joint injections?

No. Image guidance—whether fluoroscopy or CT—is bundled into CPT codes 64490–64495. Billing it separately will result in a denial. Ultrasound-guided injections require a different code set entirely (0213T–0218T), which also includes guidance in the descriptor.

03What is the KX modifier and when is it required for facet injections?

The KX modifier signals to Medicare that the service meets LCD coverage criteria for a diagnostic facet injection. It is appended to the claim line for the first two diagnostic injections. Appending it beyond those sessions—or to therapeutic injections—without documented justification (negative initial response requiring testing at a new level) can trigger focused medical review.

04Can radiofrequency ablation codes (64633–64636) be used for pulsed radiofrequency or chemical denervation?

No. These codes are reserved for thermal ablation above 80°C. Non-thermal techniques—including pulsed radiofrequency, chemical denervation, or low-grade thermal energy below 80°C—must be reported with CPT 64999, which is non-covered under Medicare.

05How many units can be reported for chemodenervation of a facet joint when two nerves are treated?

One unit per joint, not one unit per nerve. Although each facet joint has two innervating medial branch nerves, codes 64633–64636 are reported per joint. Reporting two units for one joint by counting nerves separately will be denied as a duplicate.

06What happens if an unapproved biological is injected into the facet joint?

Under CMS Benefit Policy Manual Chapter 16, Section 180, injecting biologicals or substances not designated for facet joint use causes the entire claim to deny—not just the line item for the injection.

Sources & references

Editorial content was developed using the following public sources. Last verified May 8, 2026.

Mira AI Scribe

MIRA SCRIBE GUIDANCE — FACET JOINT INJECTION Capture the following in the procedure note to support accurate code selection and payer compliance: 1. SPINAL REGION & LEVEL(S): Document exact vertebral level(s) treated (e.g., L3-4, L4-5, L5-S1). Mira maps these to the correct base code (64490 for cervical/thoracic first level; 64493 for lumbar/sacral first level) and add-on codes for each additional level. 2. LATERALITY: State unilateral (left or right) or bilateral explicitly. Bilateral same-level injections → modifier -50 on the base or add-on code. Multiple levels on the same side → add-on codes without -50. 3. INJECTION TYPE: Specify diagnostic (anesthetic only, to identify pain generator) or therapeutic (corticosteroid ± anesthetic). Diagnostic injections require KX modifier under Medicare for the first two sessions. 4. IMAGING GUIDANCE: Confirm fluoroscopy or CT was used and document real-time imaging confirmation of needle placement. Do NOT bill guidance separately—it is bundled. If ultrasound was used, Mira will route to 0213T–0218T series instead. 5. INJECTATE: List the exact agent(s) administered. Biologicals or off-label substances trigger a whole-claim denial under CMS policy—flag these before claim submission. 6. RESPONSE (for diagnostic injections): Document the patient's numeric pain score pre- and post-procedure. Positive response threshold is typically ≥50% relief; some LCDs require ≥80%. This supports medical necessity for subsequent RFA coding. 7. ANESTHESIA: Facet injections do not support MAC, moderate/deep sedation, or general anesthesia billing. Do not include anesthesia codes on the same claim.

See Mira's approach

Related terms

Radiofrequency ablation (RFA) Clinical

Radiofrequency ablation (RFA) is a minimally invasive procedure that uses thermal energy in the radiofrequency range to destroy pain-transmitting nerve tissue, interrupting nociceptive signals from structures such as facet joints, the sacroiliac joint, or the genicular nerves of the knee. It is also applied percutaneously to ablate metastatic or primary bone tumors.